Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.79 |
| ▸ | HPGD | P15428 | 1/20 | 0.74 |
| ▸ | MYC | P01106 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | CASR | P41180 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | PDE6D | O43924 | 1/20 | 0.56 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.56 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL501777 | 0.87 | KDM4E (0.76) | KDM4EHSD17B10HPGDMYCTSHR | |
| SCHEMBL501667 | 0.86 | HPGD (0.84) | KDM4EHSD17B10HPGDTSHRALDH1A1 | |
| SCHEMBL5377582 | 0.86 | HPGD (0.84) | KDM4EHSD17B10HPGDTSHRALDH1A1 | |
| SCHEMBL501937 | 0.86 | HPGD (0.80) | KDM4EHSD17B10HPGDMYCTSHR | |
| SCHEMBL501617 | 0.86 | HPGD (0.84) | KDM4EHSD17B10HPGDTSHRALDH1A1 | |
| SCHEMBL5374411 | 0.85 | HPGD (1.00) | KDM4EHSD17B10HPGDTSHRKMT2A | |
| SCHEMBL501872 | 0.84 | HPGD (0.80) | KDM4EHSD17B10HPGDMYCTSHR | |
| SCHEMBL5373120 | 0.84 | KDM4E (0.72) | KDM4EHSD17B10TSHRMEN1KMT2A | |
| SCHEMBL227741 | 0.83 | KDM4E (0.74) | KDM4EHSD17B10HPGDTSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL7173170 | 0.82 | KDM4E (0.70) | KDM4EHSD17B10HPGDMYCTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7629108-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2009-12-08 | — | — | US | disclosed |
| US-20080102405-A1 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. | 2008-05-01 | — | — | US | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-7252925-B2 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2007-08-07 | — | — | US | disclosed |
| US-20050095533-A1 | Nitrogen-containing organic compound, resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. | 2005-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080102405-A1 | Nitrogen-containing organic compound, resist composition and patterning process | MDM4, MUS81, NOP2 | KDM4E 1401/4885HSD17B10 4077/4885HPGD 2728/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.